Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Invested Capital (ROIC) | 12.8% | 10.0% | 10.3% | 13.7% | 13.4% | 13.7% | 11.0% | (40.9%) | (14.6%) | (17.1%) | 2.8% | (2.0%) | 6.2% | 4.8% | 19.0% | 15.7% | 15.7% | 12.0% | 8.0% | 6.0% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is 9.8%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Invested Capital (ROIC) for Amedisys, Inc. have been 9.5% over the past three years, and 10.9% over the past five years.
As of today, Amedisys, Inc.'s Return on Invested Capital (ROIC) is 9.8%, which is higher than industry median of 4.3%. It indicates that Amedisys, Inc.'s Return on Invested Capital (ROIC) is Good.